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The small GTP-binding protein ADP-ribosylation fac-
tor 1 (ARF1) is an essential component of the molecular
machinery that catalyzes the formation of membrane-
bound transport intermediates. By using an in vitro as-
say that reproduces recruitment of cytosolic proteins
onto purified, high salt-washed Golgi membranes, we
have analyzed the role of cAMP-dependent protein ki-
nase A (PKA) on ARF1 incorporation. Addition to this
assay of either pure catalytic subunits of PKA (C-PKA)
or cAMP increased ARF1 binding. By contrast, ARF1
association was inhibited following C-PKA inactivation
with either PKA inhibitory peptide or RIIa as well as
after cytosol depletion of C-PKA. C-PKA also stimulated
recruitment and activation of a recombinant form of
human ARF1 in the absence of additional cytosolic com-
ponents. The binding step could be dissociated from the
activation reaction and found to be independent of gua-
nine nucleotides and saturable. This step was stimu-
lated by C-PKA in an ATP-dependent manner. Dephos-
phorylated Golgi membranes exhibited a decreased
ability to recruit ARF1, and this effect was reverted by
addition of C-PKA. Following an increase in the intra-
cellular level of cAMP, ARF proteins redistributed from
cytosol to the perinuclear Golgi region of intact cells.
Collectively, the results show that PKA exerts a key
regulatory role in the recruitment of ARF1 onto Golgi
membranes. In contrast, PKA modulators did not affect
recruitment of b-COP onto Golgi membranes containing
prebound ARF1.
The small GTP-binding protein known as ADP-ribosylation
factor 1 (ARF1)1 is required for the recruitment of both COPI
and adaptor coat proteins from cytosol and therefore plays an
essential regulatory role in membrane trafficking processes
along the endocytic and biosynthetic pathways (1–3). Like
other Ras-related GTPases, ARF1 cycles between inactive
GDP-bound and active GTP-bound conformations. Posttransla-
tional N-myristoylation allows ARF1 to become inserted into
membranes in a way that is coupled to the GDP-GTP confor-
mational switch (4). Thus, inactive ARF-GDP is found in cy-
tosol, whereas active ARF-GTP binds to intracellular mem-
branes in a myristate-dependent manner. Activation depends
on guanine nucleotide-exchange factors (GEFs) that promote
the exchange of GDP for GTP. Several GEFs specific for ARF
have been identified (5, 6). They all share a 200-amino acid
region, referred to as the Sec7 domain, that is responsible for
the exchange activity. However, the different ARF-specific
GEFs differ in structural organization and sensitivity to brefel-
din A, a drug that inhibits ARF1 activation and association to
Golgi membranes (7–9). It is well established that once bound
to a membrane ARF1-GTP promotes the recruitment of cyto-
solic coat components, but the exact mechanism is controver-
sial at present. According to one view, activated ARF1 interacts
directly with coat proteins serving as a membrane anchor for
them (10, 11). This model is supported by the finding that
ARF1 binds b-COP (12), a component of the coatomer complex
which along with ARF1 itself form the COPI coat (13–15).
Alternatively, the role of ARF1 in coat assembly has been
proposed to be indirect. ARF1-GTP has been shown to activate
phospholipase D, which catalyzes the hydrolysis of phosphati-
dylcholine to phosphatidic acid (16). Ktistakis et al. (17) re-
ported conditions in which, in the absence of ARF1, coatomer
could still bind to Golgi membranes containing a high level of
phosphatidic acid. Additionally to its role on coat recruitment
and phospholipase D activation, ARF1 has been described very
recently to control both sorting of cargo molecules into trans-
port vesicles (18) and the phospholipid composition of the Golgi
membranes (19).
Golgi membranes contain sites where ARF1-GTP insertion
preferentially occurs with high affinity. Although how these
docking sites are recognized is unknown at present it possibly
involves ARF1 interaction with membrane molecules (20–22).
Aluminum fluoride, an activator of heterotrimeric G proteins,
promotes stable association of both ARF1 and coatomer to a
subset of binding sites in the Golgi membranes (23). The oppo-
site effect applies to G protein bg subunits that inhibit ARF1
binding (24). Direct interaction of ARF1 with Gbg and Gas has
also been reported (25, 26). The aluminum fluoride effect may
be mediated by protein kinase C (27). ARF1 has also been
described to interact with phosphoinositides (28) and to be
involved in several cell-signaling cascades (29–33). Collec-
tively, these studies suggest that ARF1 recruitment and/or
activation could be regulated by signal transduction molecules.
We show in this report that cAMP-dependent protein kinase A
(PKA) influences the interaction of ARF1 with the Golgi mem-
branes. Addition of exogenous PKA catalytic subunits (C-PKA)
increased binding of both cytosolic and recombinant ARF1 to
purified Golgi membranes, whereas either depletion or inacti-
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vation of endogenous C-PKA decreased ARF1 binding. In ad-
dition, PKA activation caused ARF redistribution in intact
cells. These data indicate that PKA exerts a key regulatory role
in ARF1 recruitment from cytosol to intracellular membranes.
Such effect explains the influence of PKA activity on protein
transport processes along the exocytic (34–39) and endocytic
(34, 39–42) pathways and is discussed in the context of evag-
ination of transport intermediates from donor membranes. In
particular, we propose the existence of protein targets in the
Golgi membranes that when phosphorylated by PKA act as
high affinity sites for ARF1 binding.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents—Mouse monoclonal antibody 1D9 recogniz-
ing ARF1, -3, -5, and -6 was a generous gift of Dr. R. A. Kahn (Emory
University). M2 anti-FLAG and M3A5 anti-b-COP mouse monoclonal
antibodies were from Sigma. A polyclonal antibody against bacterially
expressed His-tagged Ca subunit of murine PKA (anti-C-PKA) was
raised in rabbits. Antisera were subjected to ammonium sulfate precip-
itation and affinity-purified on recombinant protein coupled to acti-
vated Sepharose 4 (Amersham Pharmacia Biotech). Rabbit polyclonal
antibody against Golgi mannosidase II has been previously described
(43). Goat anti-mouse or anti-rabbit IgG secondary antibodies conju-
gated to fluorescein or rhodamine were from Tago (Burlingame, CA),
and secondary antibodies conjugated to peroxidase were from BIO-
SOURCE International (Camarillo, CA). C-PKA and calphostin C were
purchased from Calbiochem; PKI, forskolin, nucleotides, okadaic acid,
and apyrase were from Sigma, and proteinase K and calf intestinal
alkaline phosphatase were from Roche Molecular Biochemicals. Puri-
fied, recombinant RIIa was prepared as described previously (44).
Cytosol Preparations—Bovine brain cytosol was prepared according
to Taylor et al. (45). Briefly, brains were homogenized at 4 °C in 25 mM
Tris-HCl, pH 8.0, 500 mM KCl, 250 mM sucrose, 1 mM DTT, 1 mM
phenylmethylsulfonyl fluoride and centrifuged at 100,000 3 g for 1 h.
Supernatant was dialyzed extensively against 25 mM Hepes-KOH (pH
7.2), 25 mM KCl, 2.5 mM MgCl2, and centrifuged at 30,000 3 g for 30
min to remove precipitates. To immunodeplete C-PKA, 6 ml of crude
cytosol (9 mg/ml) were incubated overnight at 4 °C with 3.5 mg of
anti-C-PKA IgG and passed twice over a 4-ml protein A-Sepharose
CL-4B column (Sigma). C-PKA-depleted cytosol was then concentrated
to the original volume using an Ultrafree-10K (Millipore, Bedford, MA).
For ARF depletion, 2 ml of concentrated cytosol (60 mg/ml) was frac-
tionated at 24 ml/h on a Sephacryl S-200 column (60 3 2.6 cm, Amer-
sham Pharmacia Biotech) equilibrated in cytosol buffer. Fractions that
were shown by Western blotting to be depleted of ARF1 were pooled and
concentrated at 7.5 mg/ml. A comparative immunoblotting analysis of
the different cytosol preparations used is shown in Fig. 1.
Golgi Membrane Preparations—Intact Golgi stacks were prepared
from rat liver as described (46). Membranes were incubated on ice with
3 M KCl for 10 min, recovered by centrifugation (12,000 3 g, 20 min) on
a 2 M sucrose cushion, resuspended in 25 mM Hepes-KOH, pH 7.2, 25
mM KCl, 2.5 mM MgCl2, at 1 mg/ml, frozen in liquid nitrogen, and stored
at 280 °C.
Preparation of Recombinant ARF1-FLAG—Recombinant baculovirus
encoding human ARF1 tagged at the carboxyl terminus with the FLAG
epitope was generated as described previously (47). Sf9 insect cells (2 3
108) were infected with 0.1 plaque-forming unit/cell for 1 h. They were
harvested 48 h after infection and lysed in 4 ml of 50 mM Tris-HCl, pH
8.0, containing 400 mM NaCl, 5 mM EDTA, 1% (v/v) Triton X-100, 100
mM GDP, and protease inhibitors (5 mM benzamidine, 1 mM phenyl-
methylsulfonyl fluoride, 100 mg/ml soybean trypsin inhibitor, 20 mg/ml
aprotinin, and 10 mg/ml of each leupeptin, antipain, and pepstatin A).
Cell lysate was clarified by centrifugation (20,000 3 g, 20 min), and the
supernatant was incubated overnight at 4 °C with 1 ml of anti-FLAG
M2 affinity gel (Sigma). Beads were rinsed three times with lysis buffer,
and bound ARF1-FLAG was eluted with acid. Protein was dialyzed
against 20 mM Tris-HCl, pH 7.5, 10 mM EDTA, 5 mM MgCl2, 10% (v/v)
glycerol, concentrated at 0.2 mg/ml, and stored at 280 °C. Similar
results to those reported in the present study with ARF1-FLAG were
obtained with a myristoylated, untagged form of ARF1 expressed in
bacteria and purified according to Liang and Kornfeld (48).
ARF1/b-COP Binding Assay—Binding of either ARF1 or b-COP to
Golgi membranes was assayed in 1.5-ml siliconized microcentrifuge
tubes at 37 °C for 15 min according to a previously described method
(48–50). 10 mg of high salt-washed Golgi membranes were incubated
with 25 mM GTPgS, ATP-regenerating system (1 mM ATP, 5 mM crea-
tine phosphate, and 10 units/ml creatine kinase), and either 3 mg/ml
cytosol or 2 mg of recombinant ARF1-FLAG in 25 mM Hepes-KOH (pH
7.2), 25 mM KCl, 2.5 mM MgCl2, 1 mM DTT. The final volume of the
assay was 50 ml. The reaction was stopped by transferring the tubes to
ice and adding 1 ml of ice-cold assay buffer to each tube. Samples were
transferred to new siliconized microcentrifuge tubes and centrifuged at
12,000 3 g for 20 min. Membranes were recovered on a 35-ml 2 M
sucrose cushion and transferred to new tubes. They were washed twice
with assay buffer followed by solubilization in electrophoresis sample
buffer. Proteins were reduced with 10 mM DTT and analyzed by 12.5%
SDS-PAGE and immunoblotting. Immunoblots were revealed by en-
hanced chemiluminescence (SuperSignal Ultra Chemiluminescent Sub-
strate, Pierce).
Guanine Nucleotide Exchange Assay—10-ml beads containing immu-
noabsorbed ARF1-FLAG were added to a reaction mixture consisting of
5 mg of Golgi membranes, 1 mM ATP, 1 mg/ml BSA, 250 pmol of
[35S]GTPgS (1000 Ci/mmol) in a final volume of 50 ml of 25 mM Hepes,
pH 7.0, 50 mM potassium acetate, 2.5 mM magnesium acetate, 1 mM
DTT. Incubation was carried out at 37 °C for 15 min in 1.5-ml sili-
conized microcentrifuge tubes. Samples were cooled on ice, and then 1
ml of ice-cold assay buffer was added to each tube, and the complete
mixture was transferred to a new presiliconized microcentrifuge tube.
Beads were washed twice with assay buffer before 35S quantitation by
liquid scintillation counting. Samples lacking either Golgi membranes
or ARF1-FLAG were similarly processed and used to determine back-
ground binding of [35S]GTPgS.
Experiments with Intact Cells—COS-7 and NRK cells were cultured
in high glucose Dulbecco’s modified Eagle’s medium supplemented with
10% (v/v) fetal calf serum, 2 mM glutamine, 50 units/ml penicillin, and
50 mg/ml streptomycin. In experiments involving treatment with fors-
kolin, they were first preincubated in serum-free medium for 2 h at
37 °C. For subcellular fractionation, cells were pelleted, rinsed with cold
PBS, and resuspended in 3 ml of PBS containing protease inhibitors.
They were homogenized in a ball-bearing homogenizer. The postnuclear
supernatant was centrifuged at high speed (100,000 3 g, 1 h at 4 °C) to
obtain a total microsomal pellet. Membranes were rinsed, lysed in 1%
(v/v) Triton X-100, and the amount of protein determined before proc-
essing for SDS-PAGE and immunoblotting. Cells grown on round glass
coverslips were used for immunofluorescence. Microinjection was per-
formed in complete culture medium containing 25 mM Hepes using an
Eppendorf microinjection system (Hamburg, Germany). Cascade blue-
conjugated bovine serum albumin (Molecular Probes, Eugene, OR) was
used as a coinjection marker. Cells to be processed for immunofluores-
cence were fixed in 3% (w/v) formaldehyde, prepared from paraformal-
dehyde, in PBS, rinsed with plain PBS first, and then with 0.5% (w/v)
bovine serum albumin, 0.05% (w/v) saponin in PBS (PBS/BSA/saponin).
Incubation with antibodies, diluted in PBS/BSA/saponin, was per-
formed in a moist chamber at 37 °C for 30 min. Coverslips were rinsed
with PBS and mounted in 10% PBS, 90% glycerol.
RESULTS
Effect of PKA on Binding of Cytosolic ARF1 to Golgi Mem-
branes—An in vitro binding assay was used to study recruit-
ment of endogenous ARF1 from cytosol to the Golgi (48–50).
Golgi membranes, deprived of peripheral proteins by high salt
wash, were incubated at 37 °C with cytosol in the presence of
ATP-generating system and GTPgS, which makes ARF binding
FIG. 1. Analysis of different cytosol preparations. Three differ-
ent cytosol preparations were used as follows: crude bovine brain cy-
tosol (lane 1), C-PKA-depleted cytosol (lane 2), and ARF-depleted cy-
tosol (lane 3). 10 mg of each preparation were analyzed by SDS-PAGE
and immunoblotting with anti-b-COP (M3A5), anti-C-PKA, and anti-
ARF1 (1D9) antibodies.
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relatively irreversible. Membranes were then reisolated, rinsed
with buffer, and bound ARF1 detected by immunoblotting with
1D9 monoclonal antibody. While efficient recruitment of cyto-
solic ARF1 occurred during incubation of Golgi membranes
with the other components, no apparent signal was detected
when either membranes or cytosol were omitted from the in-
cubation medium (Fig. 2). ARF1 binding was drastically re-
duced although not completely abolished (see below) in the
absence of either ATP or GTPgS. The role of ATP was further
investigated. ARF1 incorporation was increased 3–4-fold fol-
lowing preincubation for 30 min at 37 °C of crude cytosol with
10–20 mM okadaic acid, a specific serine/threonine phosphatase
inhibitor (Fig. 2). This suggested the involvement of protein
kinase activities in ARF1 recruitment from cytosol.
Accordingly, addition to this assay of exogenous, pure C-PKA
slightly increased ARF1 binding. Thus, 8 units of C-PKA with
a specific activity of 750 units/mg gave rise to a 1.5–2-fold
increase (Fig. 3A). By contrast, addition of PKA regulatory
(RIIa) subunits instead of catalytic subunits decreased ARF1
incorporation (Fig. 4B). C-PKA also increased 1.2–1.6-fold
ARF1 binding to native, untreated Golgi membranes (not
shown), but in order to evaluate the PKA effect high salt-
washed membranes with little if any of prebound ARF1 were
routinely used. Additionally, to assess further this effect cy-
tosol was immunodepleted of C-PKA. As judged by immuno-
blotting, this cytosol preparation still contained ;30% of the
original C-PKA content with no apparent decrease in the pres-
ence of both ARF1 and b-COP (Fig. 1, lanes 1 and 2). In
comparison with crude cytosol ARF1 incorporation was re-
duced to less than 10% of the original value when C-PKA
depleted cytosol was used as a source of ARF1 in the binding
assay (Fig. 3A). Addition of exogenous C-PKA to this cytosol
preparation, however, reestablished ARF1 recruitment. Thus,
the level of ARF1 binding was comparable with both crude
cytosol and C-PKA-depleted cytosol supplemented with 8 units
of C-PKA. This implied a 33-fold increase in the case of C-PKA-
depleted cytosol (Fig. 3B). To exclude the possibility that the
stimulatory effect observed with C-PKA was due to a different
serine/threonine protein kinase such as PKC the experiment
was carried out in the presence of light-activated calphostin C
which at the dose used, 2 mM, inhibits most PKC isoforms. As
shown in Fig. 3 C-PKA stimulated ARF1 incorporation regard-
less of the presence or not of calphostin C in the incubation
medium.
To reveal further the PKA effect, we used a peptide, PKI,
containing the inhibitory sequence of the thermostable PKA
inhibitor, a protein that functions as a natural, highly specific
inhibitor of PKA activity (51). When added to the crude assay
this 20-amino acid sequence caused significant inhibition of
ARF1 binding (Fig. 4A). Complete inhibition required a high
(10–20 mM) concentration of PKI although a 56 6 3% decrease
was already observed at 1 nM (Fig. 4B). Although it is possible
that at high concentrations PKI has some nonspecific effects,
the fact that considerable inhibition still occurred in the nano-
molar range supported the involvement of PKA activity in
ARF1 recruitment. In addition, PKI inhibition was comparable
to that obtained with RIIa (Fig. 4C) consistent with the com-
petitive interaction of both agents with the substrate-binding
site of the kinase (52).
Effect of cAMP on ARF Redistribution—The above data sug-
gested that ARF1 recruitment could be regulated by PKA ac-
FIG. 2. Requirements for ARF1 binding to Golgi membranes. The standard binding assay consisted of high salt-washed Golgi membranes
(10 mg) incubated at 37 °C for 15 min with cytosol in the presence of ATP-regenerating system and GTPgS (control). Membranes were reisolated,
rinsed with buffer, and bound ARF1 detected by immunoblotting with 1D9 monoclonal antibody. Samples lacking either Golgi membranes, cytosol,
or GTPgS were also similarly processed. Additionally, other samples contained cytosol preincubated for 30 min at 37 °C with either 0.6 units/ml
apyrase to deplete ATP or 20 mM okadaic acid. Results derived from pretreatment on ice of Golgi membranes with 0.5 mg/ml proteinase K for 30
min prior to incubation in the complete binding assay are also shown.
FIG. 3. Effect of C-PKA addition on ARF1 recruitment from
cytosol. The binding assay contained either crude cytosol or C-PKA-
depleted cytosol, and it was supplemented with the indicated amounts
of pure C-PKA. Where indicated C-PKA-depleted cytosol preincubated
for 15 min at 37 °C with 2 mM light-activated calphostin C was used. A,
representative immunoblots of ARF1 incorporated from either crude
(control) or C-PKA-depleted cytosol are shown. B, quantitation by scan-
ning densitometry of ARF1 incorporated from both crude (E) and
C-PKA-depleted cytosol in the presence (l) or absence (l) of calphostin
C. Values are average of three different experiments and expressed as
percentage of the amount of ARF1 bound in the absence of C-PKA
added.
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tivity, and in that case, modulators of this kinase should modify
its intracellular distribution. As a first indication we studied
the effect of cAMP on the recruitment of endogenous ARF1
from crude cytosol. Addition of 5–10 mM cAMP increased ARF1
binding by 1.5-fold. By contrast, addition of AMP either had no
effect or even slightly decreased ARF1 incorporation (Fig. 5).
We next analyzed the in vivo relevance of this observation.
COS-7 cells were microinjected with either cAMP to activate
PKA or, alternatively, with AMP as a negative control. Cells
were fixed and processed for immunofluorescence to determine
the intracellular distribution of ARF proteins (Fig. 6A). Both
noninjected and AMP-injected cells showed a typical diffuse,
cytoplasmic staining pattern. In cAMP-injected cells, however,
a significant amount of ARF was concentrated in the perinu-
clear region and showed extensive colocalization with the Golgi
marker galactosyltransferase (not shown). Similarly, nonin-
jected NRK cells treated with forskolin which activates adeny-
late cyclase showed ARF redistribution from cytosol to the
Golgi where it showed colocalization with mannosidase II (Fig.
6B). ARF1 redistribution induced by forskolin was quantitated
by immunoblotting analysis of total microsomal membranes.
The amount of ARF1 associated to intracellular membranes in
cells treated with 250 mM forskolin for 30 min doubled that in
control cells (Fig. 6C). Taken together these data support a
regulatory role of PKA activity in ARF recruitment.
Effect of PKA on ARF1-FLAG Binding—In principle, PKA
may affect ARF1 incorporation by inducing the phosphoryla-
tion of particular protein substrates either in the cytosol and/or
in the Golgi membranes. To clarify this point, we examined
recruitment of a recombinant form of ARF1 containing the
FLAG epitope at the carboxyl terminus. Bound ARF1-FLAG
was detected with an antibody against the tag. As shown in Fig.
7 efficient recruitment of ARF1-FLAG occurred in the absence
of any other soluble protein. However, this incorporation was
stimulated by addition of pure C-PKA. This was particularly
evident at a low dose of both ARF1-FLAG and C-PKA. Thus, a
3.4-fold increase was observed with 1 unit of C-PKA and 2 mg of
ARF1-FLAG (Fig. 7B). Maximal stimulation, i.e. ;5-fold in-
crease, required 4 units of C-PKA, and a further increase up to
20 units of C-PKA did not cause further stimulation. Impor-
tantly, no stimulatory effect was induced in the absence of ATP
or when heat-inactivated C-PKA was used (Fig. 7B) indicating
that PKA enzymatic activity, rather than just the protein, was
necessary in order to stimulate ARF1 recruitment.
Influence of the Phosphorylation State of Golgi Membranes
on ARF1 Binding—The above data indicated that although
ARF1 can bind Golgi membranes in the absence of additional
cytosolic factors, pure C-PKA stimulates such a recruitment.
Since ARF1 itself does not contain a consensus PKA phospho-
rylation site, it was postulated that the relevant PKA sub-
strates would be Golgi integral membrane proteins that once
phosphorylated would function as high affinity binding sites for
ARF1. To test this possibility we evaluated the importance of
the phosphorylation state of the Golgi membranes for ARF1
binding. Golgi membranes were subjected to dephosphoryl-
ation by preincubation with alkaline phosphatase and then
tested for their ability to bind either recombinant ARF1-FLAG
(Fig. 8) or cytosolic ARF1 (not shown). In both cases, a signif-
icant decrease in ARF1 binding was observed following pre-
treatment of Golgi membranes with alkaline phosphatase. This
reduction ranged from 40 to 30% of the control value depending
of the amount of enzyme (50–250 units). The preparation of
alkaline phosphatase was tested for activity and shown to
cause the loss of almost 50% (47 6 5%) of 32P counts incorpo-
rated into microsomal membranes during overnight radiolabel-
FIG. 4. Effect of C-PKA inactivation on ARF1 recruitment from
cytosol. The assay that reproduces ARF1 binding from crude cytosol
was carried out. A and B, immunoblots showing ARF1 recruited from
cytosol supplemented or not (control) with either 8 units of C-PKA, 1 mM
PKI, or 1 mM RIIa. C, quantitation of the amount of ARF1 incorporated
in incubations containing the indicated concentrations of either PKI
(black bars) or RIIa (gray bars). Data represent average of three differ-
ent experiments. They are expressed as percentage of the amount of
ARF1 bound in the absence of any inhibitor.
FIG. 5. Effect of cAMP addition on ARF1 recruitment from
cytosol. The complete binding assay containing crude cytosol was
supplemented with the indicated concentrations of either cAMP (E) or
AMP (l). Data are average of two different experiments. They repre-
sent the amount of ARF1 bound to Golgi membranes and are expressed
as percentage of the amount bound in the absence of cAMP/AMP added.
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ing of COS-7 cells with 1 mCi of [32P]orthophosphate. Impor-
tantly, incubation of previously dephosphorylated Golgi
membranes with C-PKA reestablished ARF1 incorporation
(Fig. 8). Therefore, these data indicated that the phosphoryla-
tion state of the Golgi membranes affects ARF1 recruitment
and pointed to PKA as one of the kinases involved in this
process.
Effect of PKA on ARF1 Activation by Golgi Membranes—It is
well documented that in the Golgi membranes resides a GEF
activity that catalyzes the exchange of GDP for GTP on ARF1
causing its activation (7, 8, 53). Since PKA exerts its stimula-
tory role on ARF1 binding by inducing the phosphorylation of
selected Golgi proteins, we next determined whether ARF1
activation by Golgi membranes would also be affected by PKA
activity. Purified ARF1-FLAG loaded with GDP and bound to
an affinity gel was incubated at 37 °C with high salt-washed
Golgi membranes in the presence of ATP and [35S]GTPgS.
Beads were rinsed, and the radioactivity associated was meas-
ured and taken as an indication of the GDP/[35S]GTPgS ex-
change catalyzed by the Golgi membranes. Under standard
incubation conditions 2.14 6 0.6 pmol of [35S]GTPgS were
incorporated to each nmol of ARF1-FLAG. This value was
increased 1.4–1.7-fold in incubations containing 8–10 units of
C-PKA (Fig. 9). Interestingly, no stimulation occurred when
native, untreated Golgi membranes were used. In this case
membranes exhibited a strong exchange activity (higher than
15 pmol of [35S]GTPgS/nmol ARF1-FLAG) that presumably
masked a possible stimulatory effect caused by exogenous
C-PKA. Background radioactivity present in samples lacking
either Golgi membranes or ARF1-FLAG-beads was, in any
case, less than 6% of control value. Similar to what happened
with the ARF1-FLAG binding assay, the stimulatory effect
FIG. 6. Effect of PKA activation in vivo on ARF intracellular distribution. A, COS-7 cells were microinjected with 10 mM of either cAMP
or AMP mixed with 2 mg/ml cascade blue-conjugated BSA (BSA) used as co-injection marker. Cells were fixed immediately and processed for
indirect immunofluorescence with 1D9 monoclonal antibody. ARF concentration in the perinuclear region is indicated (arrowheads). Asterisks
indicate noninjected cells. Bar, 25 mm. B and C, NRK cells were preincubated at 37 °C for 2 h in serum-free medium and then incubated or not
(control) with 250 mM forskolin for 30 min. B, cells were fixed and processed for immunofluorescence with 1D9 monoclonal antibody against ARF
and polyclonal antibody against Golgi mannosidase II (Man II). Bar, 25 mm. C, total microsomal membranes were prepared from cell homogenates.
7 mg of each membrane preparation were resolved by SDS-PAGE and analyzed by immunoblotting with 1D9 monoclonal antibody against ARF.
Quantitative data (mean 6 S.D. of three different determinations) are expressed as percentage of the amount of ARF1 bound to membranes in
untreated, control cells.
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induced by C-PKA on ARF1-FLAG activation depended on the
simultaneous presence of ATP in the incubation medium (not
shown) supporting a catalytic role for PKA in this stimulation.
C-PKA Effect on ARF1 Binding Is Independent on Guanine
Nucleotides—As mentioned above for the crude binding assay
some ARF1 recruitment took place in the absence of GTPgS
FIG. 7. Effect of C-PKA addition on
ARF1-FLAG recruitment. A recombi-
nant, tagged form of human ARF1, ARF1-
FLAG, was used instead of cytosol. Pro-
tein bound to the Golgi membranes was
detected with anti-FLAG antibody. A, im-
munoblot showing ARF1-FLAG incorpo-
rated to the Golgi membranes in incuba-
tions containing or not C-PKA and
different amounts of ARF1-FLAG. B, the
binding assay contained 2 mg of ARF1-
FLAG and the indicated amounts of ei-
ther native (E) or heat-inactivated (90 °C,
30 min) (l) C-PKA. Results from incuba-
tions containing native C-PKA and
apyrase (0.6 units/ml) (l) are also shown.
FIG. 8. Effect of pretreatment of
Golgi membranes with alkaline phos-
phatase on ARF1 recruitment from
cytosol. High salt-washed Golgi mem-
branes (10 mg) were preincubated at 37 °C
for 30 min with the indicated units of calf
intestinal alkaline phosphatase in 50 mM
Tris-HCl, pH 8.0, containing 150 mM
NaCl, 1 mM MgCl2, and protease inhibi-
tors. Membranes were rinsed twice with
cold 25 mM Hepes-KOH, pH 7.2, 25 mM
KCl, 2.5 mM MgCl2, 10 mM sodium pyro-
phosphate prior to incubation in the
ARF1-FLAG binding assay. Where indi-
cated 8 units of C-PKA were added to the
assay. Data (mean 6 S.D. of three differ-
ent experiments) represent the amount of
ARF1 bound to Golgi membranes and are
expressed as percentage of the amount
bound to membranes preincubated in the
absence of alkaline phosphatase.
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(Fig. 2). This was also evident with recombinant ARF1-FLAG
in assays that were scaled up 2-fold. Binding of ARF1-FLAG to
Golgi membranes in the presence of either GDP, GTP (Fig.
10A), or in the absence of guanine nucleotides (Fig. 10B) was
strongly decreased in comparison to binding in the presence of
GTPgS. Nevertheless, the amount of ARF1-FLAG incorporated
under these conditions was sufficient to allow us to evaluate
recruitment independently of ARF activation. Therefore, we
monitored the time course of ARF1-FLAG incorporation to high
salt-washed Golgi membranes in the absence of guanine nucle-
otides in the incubation medium (Fig. 10B). Either in the pres-
ence or in the absence of C-PKA binding increased linearly
during the initial 5 min of incubation and reached saturation
over 10–15 min of incubation. At later time points, 20–30 min,
the amount of ARF1-FLAG remaining bound to the membranes
started to decrease possibly as consequence of dissociation (not
shown). At all time points examined C-PKA increased ARF1-
FLAG binding. However, the kinetic of recruitment was similar
in both cases since t1⁄2 was 0.8 min in the absence of C-PKA
versus 1.2 min in the presence of C-PKA (Fig. 10B). This sug-
gests a role for C-PKA in the generation of ARF1 high affinity
binding sites.
Effect of PKA on b-COP Recruitment—Some components of
the coatomer complex including b-COP and d-COP are serine-
phosphorylated in vivo (54) and contain consensus PKA phos-
phorylation sequences (3 sites in the case of rat b-COP and 2
sites in the case of human d-COP). We wondered whether
coatomer recruitment would also be affected by PKA activity
regardless of the PKA effects on ARF1 binding. We therefore
examined b-COP incorporation using the above binding assay
(Fig. 11). Addition of pure C-PKA to the incubation medium
containing crude cytosol resulted in a marginal (;10–20%)
increase on b-COP association to the Golgi membranes (Fig.
11A). This stimulation, however, became evident when C-PKA-
depleted cytosol was used instead. In this case, a significant
2.5-fold increase was observed following addition of 8 units of
C-PKA (Fig. 11A). It is important to note that this increase on
b-COP binding includes the stimulatory effect of C-PKA on
ARF1 binding as well. In order to strictly evaluate b-COP
incorporation, a cytosol preparation enriched in high molecular
weight proteins and practically devoid of ARF1 was obtained.
As shown in Fig. 1 (compare lanes 1 and 3) b-COP and C-PKA
were present at similar concentrations in both crude and ARF-
depleted cytosols, whereas the amount of ARF1 in the latter
was reduced from 230 mg/ml in crude cytosol to 23 mg/ml. Golgi
membranes were preincubated with recombinant ARF1-FLAG
first and then incubated with ARF-depleted cytosol (Fig. 11B).
As expected, b-COP efficiently bound to those Golgi mem-
branes that had been preincubated with ARF1-FLAG (Fig.
11B, lane 2) but not to those lacking ARF1-FLAG bound (Fig.
11B, lane 1). This corroborates the statement that coatomer
binding requires previous ARF1 incorporation (49, 50). The
effects of adding PKA modulators during the second incubation
step were then evaluated. When samples preincubated with
ARF1-FLAG were incubated with incubation medium contain-
ing ARF-depleted cytosol and supplemented with either pure
C-PKA (Fig. 11B, lane 4) or PKI (Fig. 11B, lane 3), no stimu-
latory or inhibitory effect on b-COP binding was observed. This
indicated that PKA activity had no effect on b-COP binding.
This conclusion was also supported by the observation that
apyrase decreased b-COP recruitment when added during the
first incubation step (not shown) but not when added to the
second incubation step (Fig. 11B, lane 5), indicating that in
contrast to ARF1 recruitment (Fig. 7B) ATP depletion does not
affect b-COP incorporation.
DISCUSSION
We show in this report that ARF1 association to the Golgi
complex is regulated by PKA activity. Pure catalytic subunits
of PKA (C-PKA) promoted recruitment of both endogenous,
cytosolic ARF1 and a recombinant form of human ARF1, ARF1-
FLAG, onto purified Golgi membranes. Conversely, inhibition
of endogenous PKA activity present in the cytosol with either
PKI or RIIa decreased ARF1 recruitment. Cytosol depletion
with anti-C-PKA also diminished ARF1 binding. In fact, the
stimulatory effect of C-PKA on ARF1 recruitment from cytosol
was best shown when C-PKA-depleted cytosol was used. In this
case, a significant 30-fold increase occurred. Furthermore,
ARF1 recruitment was stimulated following an increase in
cAMP concentration. In vivo this resulted in ARF1 redistribu-
tion from cytosol to the perinuclear Golgi region. Collectively,
these data indicate that ARF1 association to Golgi membranes
is positively modulated by PKA activity. One would anticipate
that the PKA stimulatory effect would be reverted by phos-
phatases present in the cytosol. Indeed, ARF1 incorporation
was increased after cytosol preincubation with okadaic acid, a
specific serine/threonine phosphatase inhibitor.
A stimulatory effect of PKC activity on ARF1 binding has
been previously reported (27). Whereas it is possible that ARF1
recruitment to intracellular membranes including the Golgi
FIG. 9. Effect of C-PKA addition on
ARF1-FLAG activation. Beads with
GDP-ARF1-FLAG bound were incubated
at 37 °C for 15 min with Golgi mem-
branes, ATP, [35S]GTPgS, and the indi-
cated amounts of pure C-PKA. They were
rinsed and processed for liquid scintilla-
tion counting. Data (mean 6 S.D.) are
average of three different determinations.
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complex is regulated by more than one protein kinase, the data
here described do not seem to be related to PKC activation.
Thus, PKC activity is not expected to be affected by reagents
such as C-PKA, RIIa, PKI, and cAMP which are natural, spe-
cific modulators of PKA activity. In addition, C-PKA stimu-
lated ARF1 recruitment in the presence of calphostin C, a
potent PKC inhibitor. On the other hand, the stimulatory effect
observed with C-PKA was saturable with respect to both dose
and time. This and results obtained with PKI and RIIa argue
against the possibility that the observed effects merely reflect
the introduction of negative charges onto the membranes that
could affect ARF1 binding nonspecifically. Instead, the results
support a specific role of PKA activity in ARF1 recruitment
from cytosol onto the Golgi membranes.
ARF1 is an ubiquitous, abundant protein involved in multi-
ple cellular functions (5). As far as transport activities are
concerned, ARF1 mediates recruitment of COPI (49, 50), AP-1
(21, 55), and AP-3 (56) complexes that accounts for the involve-
ment of this small GTP-binding protein in a variety of trans-
port pathways including anterograde and retrograde transport
between the endoplasmic reticulum and the Golgi (57, 58),
intra-Golgi transport (45), and transport from the Golgi to
either endosomes or the plasma membrane (59, 60). Also, en-
dosome fusion (61) and nuclear envelope fusion (62) as well as
the biogenesis of peroxisomes (63) and secretory (59, 64) and
synaptic (65) vesicles have been reported to occur in an ARF1-
dependent manner. In addition, a growing body of evidence
suggests that ARF1 is involved in signal transduction events
(29–33), cell growth and division (66), cytoskeleton rearrange-
ments (67–70), cell adhesion (71), and the maintenance of or-
ganelle structure (72–76). It is evident from the multiplicity of
functional roles assigned to this protein, the number of differ-
ent molecules interacting with it, and from the diversity of
ARF1-mediated transport steps that mechanisms must exist
that determine the particular effects in each case. In this re-
spect, ARF1 recruitment to particular subcellular locations
most likely determines downstream effects. In the case of the
Golgi membranes two different pools of prebound ARF1 have
been characterized (20). One was a loosely bound, nonsaturable
pool of molecules extractable with liposomes, and the other was
a tightly bound pool of ARF1 molecules that resisted liposome
extraction. The latter pool was hypothesized to comprise ARF1
molecules interacting with a putative membrane receptor (20).
Recruitment of AP-1 adaptor complex onto the trans-Golgi
network (TGN) has also been described to require previous
ARF1 interaction with a docking protein (21, 22). In support of
this model is our finding that Golgi membranes incubated with
proteinase K exhibited a decreased ability to recruit ARF1 (Fig.
2). Nevertheless, the fact that ARF1 can bind native, untreated
Golgi membranes in vitro suggests that if a receptor is required
it is already present in the purified membranes in a functional
conformation. According to our data the receptor would be a
protein that is tightly associated to the membrane since it
resisted high salt extraction and its interaction with ARF1
would be modulated by phosphorylation. Thus, ARF1 recruit-
ment was dramatically decreased following dephosphorylation
with alkaline phosphatase of high salt-washed Golgi mem-
branes. The fact that addition of pure C-PKA reestablished the
capacity of previously dephosphorylated Golgi membranes to
recruit ARF1 suggests that this kinase plays a relevant role in
the activation of the putative receptor. It is also important to
note that as expected from the interaction of soluble ARF1
with a PKA-sensitive receptor the stimulatory effect of adding
C-PKA to the binding assay was saturable.
C-PKA slightly increased the exchange of GDP for GTP on
ARF1 in the presence of Golgi membranes. It is therefore
possible that PKA plays a role in ARF1 activation either by
somehow stimulating spontaneous nucleotide exchange or, al-
ternatively, throughout the regulation of a still uncharacter-
ized GEF protein associated to the Golgi membranes. Although
this issue remains open at present, additional data indicate
that the primary PKA effect is exerted on ARF1 binding. This
step was shown to be independent on guanine nucleotides and
therefore could be analyzed separate from the activation reac-
tion. In the absence of guanine nucleotides, addition of C-PKA
increased ARF1 binding without modifying significantly the
kinetic of recruitment. This suggests that new ARF1 high af-
finity binding sites were generated following the C-PKA-medi-
ated phosphorylation of selective protein targets. Additionally,
these observations support a model by which binding of ARF1-
GDP to the membrane would precede the nucleotide exchange
reaction (4, 77). According to our data the former step would be
regulated by PKA activity.
ARF1 binding to a particular membrane is the prerequisite
that triggers coat assembly and ultimately evagination of a
transport intermediate (1). It has been shown previously that
interaction of AP-1 and AP-2 adaptor proteins with clathrin is
modulated by serine phosphorylation (78). This along with the
finding that in vivo the coatomer proteins b-COP and d-COP
exhibit considerable charge heterogeneity due to variable ser-
FIG. 10. Effect of C-PKA addition on the guanine nucleotide-
independent recruitment of ARF1-FLAG. The ARF1-FLAG bind-
ing assay was scaled up 2-fold. A, binding in the presence of the
indicated guanine nucleotides. B, time course of the association of
ARF1-FLAG to Golgi membranes in the absence of guanine nucleotides
added and in the presence (l) or not (E) of 8 units of C-PKA. Data are
average of two different experiments.
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ine phosphorylation (54) led us to think that in addition to
ARF1 incorporation coatomer recruitment could also be af-
fected by PKA activity. Indeed, addition of C-PKA to the bind-
ing assay increased b-COP recruitment. However, additional
data obtained with ARF-depleted cytosol and Golgi membranes
containing prebound ARF1-FLAG revealed that PKA does not
influence b-COP recruitment. Thus, addition of either C-PKA
or PKI did not affect b-COP binding when this association was
evaluated in an ARF1-independent way. These data, therefore,
indicate that PKA activity stimulates evagination of transport
intermediates by primarily increasing ARF1 recruitment.
PKA activity has been involved in a number of transport
events including transport from the endoplasmic reticulum to
the Golgi (37), across the Golgi stack (37), and from the TGN to
the plasma membrane (35–37, 39). Also, exocytosis (79), endo-
cytosis (40–42), and transcytosis (34, 39) have been described
to be regulated by PKA activity. We have recently reported that
PKA activity is required for the generation of TGN-derived
constitutive transport vesicles containing the envelope glyco-
protein of vesicular stomatitis virus (38). Very recently these
vesicles have also been shown to be formed in vitro in an ARF-
and coatomer-dependent manner (60, 80). By generalization, it
can be speculated that PKA has a general, regulatory role in
most membrane trafficking processes. That would be the for-
mation of transport vesicles from a donor compartment by
controlling the amount of ARF1 recruited onto the membrane.
The data shown here provide evidence that PKA could do this
by inducing the phosphorylation of an ARF1-specific receptor
located in the membrane.
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